Evaxion Biotech A/S
EVAX
$1.65
$0.063.77%
NASDAQ
| 12/31/2024 | 06/30/2024 | 12/31/2023 | 09/30/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -- | -- | -4.52M | -5.68M | -5.68M |
| Total Depreciation and Amortization | -- | -- | 115.00K | 200.00K | 200.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | -- | 995.00K | 781.00K | 781.00K |
| Change in Net Operating Assets | -- | -- | 1.41M | 307.00K | 307.00K |
| Cash from Operations | -- | -- | -2.01M | -4.39M | -4.39M |
| Capital Expenditure | -- | -- | 1.00K | -65.00K | -65.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 0.00 | 0.00 | 0.00 |
| Cash from Investing | -- | -- | 1.00K | -65.00K | -65.00K |
| Total Debt Issued | -- | -- | 0.00 | 65.00K | 65.00K |
| Total Debt Repaid | -- | -- | -118.00K | -119.00K | -119.00K |
| Issuance of Common Stock | -- | -- | 3.04M | 154.00K | 154.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 2.34M | -4.00K | -4.00K |
| Cash from Financing | -- | -- | 5.26M | 96.00K | 96.00K |
| Foreign Exchange rate Adjustments | -- | -- | -274.00K | -154.00K | -154.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -- | 2.98M | -4.51M | -4.51M |